System Dynamics Modeling Can be Leveraged to Predict Critical Care Pathways and Costs for End Stage Renal Disease: US Population to 2020

Authors: Luca Fernandez1, Christopher Koliba1, Asim Zia1, Katharine Cheung2, Richard Solomon2, Christopher Jones3

JHEOR 2015;3(1):24-33

Register or Login to Read More

Cost-effectiveness of Catheter Ablation versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective

Authors: Yaariv Khaykin1, Peter J. Mallow2, John A. Rizzo3, Atul Verma1, Lauren Chun1, Shelby Olesovsky1, Matthew R. Reynolds4

JHEOR 2015;3(1):1-12

Register or Login to Read More

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR

Authors: Mike Durkin1, Jacqueline Pesa2, Jessica Lopatto3, Rachel Halpern4, Stephanie Korrer4, Damon Van Voorhis4

JHEOR 2015;2(2):221-32

Register or Login to Read More

Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment

Authors: Ken Okumura1*, Hiroshi Inoue2, Masahiro Yasaka3, Juan Marcos Gonzalez4, A. Brett Hauber4, Bennett Levitan5, Zhong Yuan5, Jean Baptiste Briere6

 JHEOR 2015;2(2):207-20

Register or Login to Read More

Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland

Authors: Anke van Engen1, Montserrat Casamayor2, Fidelma Loftus3, Martin Coen3, Andy Garnham4, Maureen Watt4, Larry Lacey5

 JHEOR 2015;2(2):192-206

Register or Login to Read More

Health Care Costs attributable to Hospital-diagnosed Back Pain: A Longitudinal Register-based Study of the Danish Population

Authors: Rikke Søgaard1, Jan Sørensen1

JHEOR 2014;1(3):266-75

Login or Register to Read More

Generalized Propensity Score Matching with Multilevel Treatment Options

Author: Onur Baser

JHEOR 2013; 1(1):1-13

Login or Register to Read More

Cost Analysis and Clinical Outcomes of Ambulatory Care Monitoring in Medicare Patients: Describing the Diagnostic Odyssey

Authors: Renée JG Arnold1,2,3*, Andrew Layton1

 JHEOR 2015;2(2):161-9

Login or Register to Read More

Explaining Obesity and Smoking-related Healthcare Costs through Unconditional Quantile Regression

Authors: Bijan Borah1, James Naessens1, Kerry Olsen2, Nilay D. Shah1

JHEOR 2013; 1(1):23-41

Login or Register to Read More

The Cost-effectiveness of Celecoxib versus Non-steroidal Anti-inflammatory Drugs plus Proton-pump Inhibitors for Treating Osteoarthritis in Algeria

Authors: Nadir Hammoumraoui1, Sid Ahmed Kherraf2, Joaquin Mould-Quevedo3, Tarek A. Ismail4

JHEOR 2013;1(2):184-99

Login or Register to Read More

System Dynamics Modeling Can be Leveraged to Predict Critical Care Pathways and Costs for End Stage Renal Disease: US Population to 2020

Authors: Luca Fernandez1, Christopher Koliba1, Asim Zia1, Katharine Cheung2, Richard Solomon2, Christopher Jones3

JHEOR 2015;3(1):24-33

Register or Login to Read More

Cost-effectiveness of Catheter Ablation versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective

Authors: Yaariv Khaykin1, Peter J. Mallow2, John A. Rizzo3, Atul Verma1, Lauren Chun1, Shelby Olesovsky1, Matthew R. Reynolds4

JHEOR 2015;3(1):1-12

Register or Login to Read More

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR

Authors: Mike Durkin1, Jacqueline Pesa2, Jessica Lopatto3, Rachel Halpern4, Stephanie Korrer4, Damon Van Voorhis4

JHEOR 2015;2(2):221-32

Register or Login to Read More

Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment

Authors: Ken Okumura1*, Hiroshi Inoue2, Masahiro Yasaka3, Juan Marcos Gonzalez4, A. Brett Hauber4, Bennett Levitan5, Zhong Yuan5, Jean Baptiste Briere6

 JHEOR 2015;2(2):207-20

Register or Login to Read More

Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland

Authors: Anke van Engen1, Montserrat Casamayor2, Fidelma Loftus3, Martin Coen3, Andy Garnham4, Maureen Watt4, Larry Lacey5

 JHEOR 2015;2(2):192-206

Register or Login to Read More

Mission

journal-smallThe mission of the Journal of Health Economics and Outcomes Research (JHEOR) is to combine the highest academic standards using peer review and a speedy publication process commensurate with the productivity of the industry.  JHEOR aims to contribute to the development of methodological standards in the field with rapid publication, validated by rigorous peer view.

Read more...

News From Our Desk

Author Feedback

 

"Thanks a lot. It was very efficient work and nice design." JHEOR author (06AUG2014)

 

"Thanks a lot for this fast and efficient publication process. It is impressively efficient." JHEOR author (04OCT2013)

 

"This has been a very quick, seamless and just as “advertised” publication experience." JHEOR author (22AUG2013)

 

"It has been a pleasure to work with you through the review and proof process. Your attention and timeliness are much appreciated." JHEOR author (28JUL2013) 

Read more...

ISPOR

JHEOR will exhibit at the ISPOR 5th Latin America Conference, to be held 7 September 2015, in Santiago, Chile 

Read more...

Submission to Publication

Manuscripts submitted to JHEOR are reviewed within 1 week. Accepted manuscripts are published as early as 24 hours after acceptance.

Indexed By

  • Google Scholar
  • OCLC
  • SCOPUS
  • Summon by Serial Solutions
  • EMBASE
  • EBSCO
  • ProQuest
  • Academic OneFile
  • Business Source
  • Current Abstracts
  • Current Index to Statistics
  • EMCare
  • Gale
  • SCImago
  •  
  • Online: ISSN 2327-2236
  • Print: ISSN 2326-697X

Journal of Health Economics and Outcomes Research

An A2 Publications Journal

211 N. 4th Avenue, Suite 2A

Ann Arbor, MI 48104

Phone: 1-734-392-4850 Fax: 1-734-864-0308